Wave Life Sciences Ltd.

NASDAQ: WVE · Real-Time Price · USD
9.60
0.69 (7.74%)
At close: Aug 15, 2025, 1:06 PM

Wave Life Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
108.3M 113.31M 3.65M 40.96M
Cost of Revenue
n/a 9.21M 10.11M 121.88M
Gross Profit
108.3M 104.1M -6.46M -80.91M
Operating Income
-110.4M -68M -162.72M -127.02M
Interest Income
n/a n/a n/a 30K
Pretax Income
-97.01M -58.19M -161.14M -122.45M
Net Income
-97.01M -57.51M -161.82M -122.25M
Selling & General & Admin
59.02M 51.29M 50.51M 46.1M
Research & Development
159.68M 130.01M 115.86M 121.88M
Other Expenses
n/a n/a 7K 4.54M
Operating Expenses
218.71M 181.3M 166.37M 167.98M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
218.71M 181.3M 166.37M 167.98M
Income Tax Expense
n/a -677K 681K -204K
Shares Outstanding (Basic)
138.28M 106.1M 78.86M 51.83M
Shares Outstanding (Diluted)
138.28M 106.1M 78.86M 51.83M
EPS (Basic)
-0.7 -0.54 -2.05 -2.36
EPS (Diluted)
-0.7 -0.54 -2.05 -2.36
EBITDA
-101.74M -58.79M -152.61M -117.18M
EBIT
-110.4M -68M -162.72M -127.02M
Depreciation & Amortization
8.66M 9.21M 10.11M 9.84M